Fortrea Holdings Inc (FTRE)

NASD · Healthcare · Biotechnology · USA

Fortrea Holdings Inc is a small cap company (market value between $300 million and $2 billion) in the Biotechnology industry.

Fortrea Holdings is a global contract research organization supporting pharmaceutical, biotechnology, and medical device companies with clinical study management, clinical pharmacology services, and strategic consulting. The company executes phase I through IV trials and real-world evidence research spanning multiple therapeutic areas worldwide through tailored service arrangements.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Fortrea Holdings Inc stock.

Our verdict on FTRE

Not valued: We cannot value this company yet.

We do not publish a value for this company: a figure this valuation depends on is missing.

ETFs with the most weight in FTRE

17 more funds hold it; the full list is part of the paid plan.

Browse

Peers in Biotechnology

All 600 Biotechnology stocks

Cheaper than FTRE in Biotechnology

129 more in this industry show a wider margin of safety.

Is FTRE undervalued or overvalued?

We do not publish a verdict on FTRE yet. We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.

What is the intrinsic value of FTRE?

We do not publish one (as of the 2026-11-17 close). We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.